Novocaine Tops North America's Slowest Box Office Weekend

Paramount's action-comedy 'Novocaine' topped the North American box office with an opening weekend of $8.7 million, marking one of the slowest weekends in 2025 and the post-COVID-19 era. The film managed to outperform Warner Bros.' 'Mickey 17', which dropped to second place with $7.51 million, and Focus Features' 'Black Bag', which debuted in third at $7.5 million. Despite its number one position, 'Novocaine' fell short of initial expectations of reaching $10 million. This weekend's total box office revenue was approximately $54.7 million, indicating a significant slump in attendance compared to previous years. The performance of 'Novocaine' and other new releases reflects a larger trend of declining theatrical attendance, influenced by the rise of streaming services. Anticipation builds for upcoming releases, including Disney's 'Snow White', which is projected to revitalize box office numbers next weekend.